Literature DB >> 8994221

Neurite outgrowth in PC12 cells is enhanced by guanosine through both cAMP-dependent and -independent mechanisms.

J W Gysbers1, M P Rathbone.   

Abstract

Extracellular guanosine, guanosine triphosphate (GTP), and 5'-N'-ethylcarboxamidoadenosine (NECA), each significantly enhanced the proportion of nerve growth factor (NGF)-treated rat pheochromocytoma (PC12) cells which had neurites, greater than that in cultures exposed to NGF alone. Guanosine and NECA, but not GTP, increased intracellular cAMP concentrations. An adenylate cyclase inhibitor, SQ22536, completely blocked the cAMP increase induced by both guanosine and 0.1 microM NECA. However, SQ22536 only partially blocked guanosine enhanced neurite outgrowth, although it completely blocked the neuritogenic effect of NECA. Therefore guanosine-enhanced neurite outgrowth through both cAMP-dependent and -independent mechanisms, while the effect of GTP was cAMP-independent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8994221     DOI: 10.1016/s0304-3940(96)13253-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  18 in total

1.  Guanosine and GMP increase the number of granular cerebellar neurons in culture: dependence on adenosine A2A and ionotropic glutamate receptors.

Authors:  Helena Decker; Tetsade C B Piermartiri; Cláudia B Nedel; Luciana F Romão; Sheila S Francisco; Tharine Dal-Cim; Carina R Boeck; Vivaldo Moura-Neto; Carla I Tasca
Journal:  Purinergic Signal       Date:  2019-09-02       Impact factor: 3.765

2.  Sustained delivery of dibutyryl cyclic adenosine monophosphate to the transected spinal cord via oligo [(polyethylene glycol) fumarate] hydrogels.

Authors:  Gemma E Rooney; Andrew M Knight; Nicolas N Madigan; Louann Gross; Bingkun Chen; Catalina Vallejo Giraldo; Seungmae Seo; Jarred J Nesbitt; Mahrokh Dadsetan; Michael J Yaszemski; Anthony J Windebank
Journal:  Tissue Eng Part A       Date:  2011-02-05       Impact factor: 3.845

3.  Specific [(3)H]-guanosine binding sites in rat brain membranes.

Authors:  Ugo Traversa; Giulia Bombi; Patrizia Di Iorio; Renata Ciccarelli; Eva S Werstiuk; Michel P Rathbone
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

4.  Mechanisms involved in the antinociception induced by systemic administration of guanosine in mice.

Authors:  A P Schmidt; A E Böhmer; C Schallenberger; C Antunes; R G Tavares; S T Wofchuk; E Elisabetsky; D O Souza
Journal:  Br J Pharmacol       Date:  2010-02-02       Impact factor: 8.739

5.  Vital role of protein kinase C-related kinase in the formation and stability of neurites during hypoxia.

Authors:  Bettina Thauerer; Stephanie zur Nedden; Gabriele Baier-Bitterlich
Journal:  J Neurochem       Date:  2010-01-28       Impact factor: 5.372

Review 6.  Cytoskeletal and signaling mechanisms of neurite formation.

Authors:  Rajiv Sainath; Gianluca Gallo
Journal:  Cell Tissue Res       Date:  2014-07-31       Impact factor: 5.249

Review 7.  Guanosine and its role in neuropathologies.

Authors:  Luis E B Bettio; Joana Gil-Mohapel; Ana Lúcia S Rodrigues
Journal:  Purinergic Signal       Date:  2016-03-22       Impact factor: 3.765

8.  HIF-1 alpha is an essential effector for purine nucleoside-mediated neuroprotection against hypoxia in PC12 cells and primary cerebellar granule neurons.

Authors:  Stephanie zur Nedden; Bettina Tomaselli; Gabriele Baier-Bitterlich
Journal:  J Neurochem       Date:  2008-02-04       Impact factor: 5.372

9.  Investigating the Role of Guanosine on Human Neuroblastoma Cell Differentiation and the Underlying Molecular Mechanisms.

Authors:  Natale Belluardo; Giuseppa Mudò; Valentina Di Liberto; Monica Frinchi; Daniele F Condorelli; Ugo Traversa; Francisco Ciruela; Renata Ciccarelli; Patrizia Di Iorio; Patricia Giuliani
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

Review 10.  Purine nucleosides: endogenous neuroprotectants in hypoxic brain.

Authors:  Bettina Thauerer; Stephanie Zur Nedden; Gabriele Baier-Bitterlich
Journal:  J Neurochem       Date:  2012-03-14       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.